Director Shareholding

Dechra Pharmaceuticals PLC
21 September 2000


         DECHRA PHARMACEUTICALS PLC ('DECHRA' OR THE 'COMPANY')
                                    
                        NOTIFICATION OF INTERESTS
                                    
Following Dechra's admission to the Official List, the directors of Dechra 
have the following beneficial interests in the share capital of the Company:


Director            Number of   Percentage of issued
                       shares          share capital

Peter Redfern         359,486                    0.7
Garry Evans         1,372,334                    2.8
Simon Evans           638,000                    1.3
Ian Page              592,167                    1.2
Edwin Torr            342,414                    0.7
Michael Annice        596,334                    1.2
Malcolm Diamond             0                    0.0
                               

The following options over ordinary shares in Dechra ('Shares') were granted
to the directors of Dechra under the Executive Share Plan on 14 September
2000:

Director                   Number of
                            Options
                        
Gary Evans                  166,666
Simon Evans                 145,833
Ian Page                    166,666
Edwin Torr                  166,666
Michael Annice              104,166
                        

The receipt of Shares under the Executive Share Plan is subject to performance
conditions, details of which are set out in the prospectus issued by Dechra
dated 24 August 2000.